1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine has been researched along with calpain inhibitor iii in 2 studies
Studies (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine) | Trials (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine) | Recent Studies (post-2010) (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine) | Studies (calpain inhibitor iii) | Trials (calpain inhibitor iii) | Recent Studies (post-2010) (calpain inhibitor iii) |
---|---|---|---|---|---|
9 | 0 | 2 | 187 | 0 | 76 |
Protein | Taxonomy | 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine (IC50) | calpain inhibitor iii (IC50) |
---|---|---|---|
Calpain-9 | Homo sapiens (human) | 1.61 | |
Calpain-1 catalytic subunit | Homo sapiens (human) | 0.183 | |
Procathepsin L | Homo sapiens (human) | 0.6365 | |
Cathepsin B | Homo sapiens (human) | 0.5186 | |
Calpain-2 catalytic subunit | Homo sapiens (human) | 0.35 | |
Calpain-1 catalytic subunit | Sus scrofa (pig) | 0.02 | |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.1 | |
Falcipain 2B | Plasmodium falciparum (malaria parasite P. falciparum) | 5 | |
Cysteine proteinase falcipain 2a | Plasmodium falciparum (malaria parasite P. falciparum) | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
2 other study(ies) available for 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine and calpain inhibitor iii
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |